primary hyperoxaluria

1 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Arbor Biotech Names Veteran Gene Therapy Expert Pletcher as Chief Scientific Officer

Arbor Biotechnologies appoints veteran gene therapy scientist Mathew Pletcher as Chief Scientific Officer, bolstering leadership as it advances pipeline programs including rare disease candidate ABO-101.
PFERHHBYrare diseasegene therapy